20 research outputs found
The Human Urine Metabolome
Urine has long been a âfavoredâ biofluid among metabolomics researchers. It is sterile, easy-to-obtain in large volumes, largely free from interfering proteins or lipids and chemically complex. However, this chemical complexity has also made urine a particularly difficult substrate to fully understand. As a biological waste material, urine typically contains metabolic breakdown products from a wide range of foods, drinks, drugs, environmental contaminants, endogenous waste metabolites and bacterial by-products. Many of these compounds are poorly characterized and poorly understood. In an effort to improve our understanding of this biofluid we have undertaken a comprehensive, quantitative, metabolome-wide characterization of human urine. This involved both computer-aided literature mining and comprehensive, quantitative experimental assessment/validation. The experimental portion employed NMR spectroscopy, gas chromatography mass spectrometry (GC-MS), direct flow injection mass spectrometry (DFI/LC-MS/MS), inductively coupled plasma mass spectrometry (ICP-MS) and high performance liquid chromatography (HPLC) experiments performed on multiple human urine samples. This multi-platform metabolomic analysis allowed us to identify 445 and quantify 378 unique urine metabolites or metabolite species. The different analytical platforms were able to identify (quantify) a total of: 209 (209) by NMR, 179 (85) by GC-MS, 127 (127) by DFI/LC-MS/MS, 40 (40) by ICP-MS and 10 (10) by HPLC. Our use of multiple metabolomics platforms and technologies allowed us to identify several previously unknown urine metabolites and to substantially enhance the level of metabolome coverage. It also allowed us to critically assess the relative strengths and weaknesses of different platforms or technologies. The literature review led to the identification and annotation of another 2206 urinary compounds and was used to help guide the subsequent experimental studies. An online database containing the complete set of 2651 confirmed human urine metabolite species, their structures (3079 in total), concentrations, related literature references and links to their known disease associations are freely available at http://www.urinemetabolome.ca
Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort
Background:
Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, is difficult to diagnose and has limited treatment options with a low survival rate. Aside from a few key risk factors, such as hepatitis, high alcohol consumption, smoking, obesity, and diabetes, there is incomplete etiologic understanding of the disease and little progress in identification of early risk biomarkers.
Methods:
To address these aspects, an untargeted nuclear magnetic resonance metabolomic approach was applied to pre-diagnostic serum samples obtained from first incident, primary HCC cases (nâ=â114) and matched controls (nâ=â222) identified from amongst the participants of a large European prospective cohort.
Results:
A metabolic pattern associated with HCC risk comprised of perturbations in fatty acid oxidation and amino acid, lipid, and carbohydrate metabolism was observed. Sixteen metabolites of either endogenous or exogenous origin were found to be significantly associated with HCC risk. The influence of hepatitis infection and potential liver damage was assessed, and further analyses were made to distinguish patterns of early or later diagnosis.
Conclusion:
Our results show clear metabolic alterations from early stages of HCC development with application for better etiologic understanding, prevention, and early detection of this increasingly common cancer.This work was supported by the French National Cancer Institute (LâInstitut National du Cancer; INCA; grant number 2009-139; PI: M. Jenab). AF received financial support (BDI fellowship) from the Centre National de la Recherche Scientifique (CNRS) and Bruker Biospin. The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle GĂ©nĂ©rale de lâEducation Nationale, and Institut National de la SantĂ© et de la Recherche MĂ©dicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum (DKFZ), and Federal Ministry of Education and Research (Germany); Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC), National Research Council, Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy, and AIRE-ONLUS Ragusa, AVIS Ragusa, Sicilian Government (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), and Statistics Netherlands (the Netherlands); European Research Council (ERC; grant number ERC-2009-AdG 232997) and Nordforsk, and Nordic Center of Excellence Programme on Food, Nutrition and Health (Norway); Health Research Fund (FIS), Regional Governments of AndalucĂa, Asturias, Basque Country, Murcia (No. 6236) and Navarra, and ISCIII RETIC (RD06/0020) (Spain); Swedish Cancer Society, Swedish Scientific Council, and Regional Government of SkĂ„ne and VĂ€sterbotten (Sweden); Cancer Research UK, Medical Research Council, Stroke Association, British Heart Foundation, Department of Health, Food Standards Agency, and Wellcome Trust (UK)
Concentrations of metabolites in human urine as measured by GC-MS.
*<p>Concentration of metabolite (Mean ± SD) is expressed by ”M. HPHPA: 3-(3-hydroxyphenyl)-3-hydroxypropanoic acid; NA: not available; NA**: not available for healthy adults.</p
Historic data on metabolite characterization of human urine by different platforms.
<p>Historic data on metabolite characterization of human urine by different platforms.</p
Typical GC-MS total ion chromatogram of organic acids extracted from human urine.
<p>Numbers indicate the following metabolites (quantified compounds): 1: pyruvic acid; 2: L-lactic acid; 3: alpha-hydroxyisobutyric acid; 4: glycolic acid; 5: levulinic acid; 6â¶3-hydroxyisovaleric acid; 7â¶2-hydroxy-2-methylbutyric acid; 8: hydroxypropionic acid; 9â¶2-methyl-3-hydroxybutyric acid; 10: malonic acid; 11â¶3-hydroxyisovaleric acid; 12: methylmalonic acid; 13â¶2-ethylhydracrylic acid; 14: benzoic acid; 15: phosphoric acid; 16: ethylmalonic acid; 17: succinic acid; 18: methylsuccinic acid; 19â¶4-deoxythreonic acid; 20â¶5-hydroxyhexanoic acid; 21: citraconic acid; 22: glutaric acid; 23: m-chlorobenzoic acid; 24; 3,4-dihydroxybutanoic acid; 25â¶3-methylglutaconic acid; 26: adipic acid; 27: pyroglutamic acid; 28â¶3-methyladipic acid; 29: sumikiâs acid; 30: o-hydroxyphenylacetic acid; 31: oxoglutaric acid; 32: pimelic acid; 33â¶3-hydroxymethylglutaric acid; 34â¶3-hydroxyphenylacetic acid; 35â¶4-hydroxybenzoic acid; 36â¶2-furoylglycine; 37: suberic acid; 38: quinolinic acid; 39: Cis/Trans-aconitic acid; 40: homovanillic acid; 41: azelaic acid; 42: hippuric acid; 43â¶3,4-dihydroxybenzeneacetic acid; 44â¶3-(3-hydroxyphenyl)-3-hydroxypropanoic acid (HPHPA); 45: vanillylmandelic acid; 46â¶4-hydroxyphenyllactic acid; 47: indoleacetic acid; 48: palmitic acid; 49: kynurenic acid; 50â¶3-hydroxyhippuric acid; 51â¶3-hydroxysebacic acid; 52: Trans-ferulic acid; 53â¶5-hydroxyindoleacetic acid; 54: stearic acid.</p
Chemical superclasses in the urine metabolome database.
<p>Chemical superclasses in the urine metabolome database.</p
Typical gas chromatogram of volatile organic compounds (VOC) from a pooled human urine sample.
<p>Numbers indicate the following metabolites: 1â¶3-methyl sulfolane; 2â¶3-hexanone; 3â¶2-pentanone; 4â¶1-hydroxy-2-pentanone; 5: allyl methylsulphide; 6: dimethyl disulfide; 7â¶4-heptanone; 8â¶1-methylcyclohexanol; 9; 2-hexanone; 10â¶3,4-dimethylthiophene; 11: diallyl sulphide; 12â¶5-methyl-2-hexanone; 13â¶1,3-dithio cyclohexane; 14: dimethyl trisulfide; 15: phenol; 16: o-cymene; 17: p-cymene; 18: m-cymene; 19â¶1,4-cineol; 20: p-cresol; 21: linalool oxide; 22: iso-menthol; 23: Alpha-p-dimethylstyrene; 24: L-menthol; 25: undecane; 26: ledene oxide (II); 27: salicylic acid methyl ester; 28: Beta-carvone; 29: piperitone; 30: o-thymol; 31: Beta-cyclocitrol; 32â¶4,7-dimethyl-benzofuran; 33: cuminal: 34â¶2,6,10,10 Tetramethyl-oxa-spiro-4,5-dec-6-ene; 35â¶4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butanone; 36â¶1,2,3,4-tetrahydro-1,1,6-trimethyl naphthalene; 37: Alpha-cedrene; 38â¶1,2,3,4-tetrahydro-1,5,7-trimethylnapthalene; 39â¶1,2-diydro-1,1,6-trimethyl-napthalene; 40: Beta-guaiene; 41: Beta-damascenone; 42â¶2,5-cyclohexadiene-1,4-dione-2,6-di-tert-butyl; 43: himachalene; 44â¶4-(2,6,6-trimethylcyclohexa-1,3-dienyl)-but-3-en-2-one: 45â¶1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1-penten-3-one; 46â¶2,4-Bis (1,1-dimethylethyl)-phenol; 47â¶1-(2,3,6-trimethyl phenyl)-3-buten-2-one; 48: L-calamenene; 49: Beta-vatirenene; 50â¶1,6,7-trimethylnaphthalene; 51: azulol; 52â¶3,3,5,6-tetramethyl-1-indanone.</p
Concentrations of isoflavones and thiols as determined by HPLC.
a<p>Isoflavone metabolites measured by HPLC/UV.</p>b<p>Thiol metabolites measured by HPLC/FD.</p><p>Oc: occurrence;</p><p>NA: not available.</p
Concentrations of acylcarnitines, amino acids, biogenic amines, lysophosphatidylcholines, phosphatidylcholines and sphingomyelins in human urine by combined DFI/LC-MS/MS (BIOCRATES kit).
*<p>Concentration of metabolite (Mean±SD) is expressed by ”M. aa: diacyl; ae: acyl-alkyl.</p